Skip to content
Open access · OA via OpenAlex

Modulating The Epigenetic Clock, Senolytic Therapies for Human Longevity: Age Tissue Regeneration, Synergistic Effect of Nad+ Precursors and Telomerase, Human Age Enhancement

Yash Srivastav Srivastav, Stuti Verma Verma, Kamini Prajapati Prajapati, Anup Kumar Sirbaiya Sirbaiya, Shivani Singh Singh, Amita Singh Singh, Deepshi Srivastava Srivastava

Journal of Pharmaceutical Research and Integrated Medical Sciences · 2026

Abstract

The human aging process can be characterized by progressive cellular degeneration, mitochondria malfunctioning, inflammatory responses, epigenetics modifications, and loss of tissue regenerative ability. The recent progress made in the field of longevity has revealed several promising treatment opportunities for prolonging a healthy lifespan in humans through epigenetics regulation, senolytics(definition) application, NAD+ precursors' intake, telomerase activation, and regenerative treatments. This review considers evidence from human studies about the impact of DNA methylation, cell senescence(definition) elimination, mitochondria recovery, enhanced immunity, tissue renewal, and cognitive reserve increase in human aging biology. According to findings based on human research, interventions involving senolytic compounds, Nicotinamide Riboside (NR), Nicotinamide Mononucleotide (NMN), and telomerase-linked regenerative treatment have the ability to contribute to improved metabolism, vascular functions, immunological resilience, and cognitive efficiency while reducing inflammatory processes and decreasing the number of senescent cells in a human body. In addition, comprehensive longevity approaches consisting of the mentioned interventions seem to possess combined benefits in terms of human longevity improvement. However, there are certain drawbacks that must be addressed when applying these interventions into clinical practice; namely, small sample sizes used in studies, lack of long-term safety testing, ethical issues, and inadequate biomarkers. Future directions in the research are discussed.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.64063/3049-1681.vol.3.issue6.3
Canonical
link ↗
Fetched
2026-10-09 MST

Cite this

APA
Srivastav, Y.S., Verma, S.V., Prajapati, K.P., Sirbaiya, A.K.S., Singh, S.S., Singh, A.S., &amp; Srivastava, D.S. (2026). Modulating The Epigenetic Clock, Senolytic Therapies for Human Longevity: Age Tissue Regeneration, Synergistic Effect of Nad+ Precursors and Telomerase, Human Age Enhancement. <em>Journal of Pharmaceutical Research and Integrated Medical Sciences</em>. https://doi.org/10.64063/3049-1681.vol.3.issue6.3
Vancouver
Srivastav YS, Verma SV, Prajapati KP, Sirbaiya AKS, Singh SS, Singh AS, et al. Modulating The Epigenetic Clock, Senolytic Therapies for Human Longevity: Age Tissue Regeneration, Synergistic Effect of Nad+ Precursors and Telomerase, Human Age Enhancement. Journal of Pharmaceutical Research and Integrated Medical Sciences. 2026. doi:10.64063/3049-1681.vol.3.issue6.3.
BibTeX
@article{yash2026Modula, title = {Modulating The Epigenetic Clock, Senolytic Therapies for Human Longevity: Age Tissue Regeneration, Synergistic Effect of Nad+ Precursors and Telomerase, Human Age Enhancement}, author = {Yash Srivastav Srivastav and Stuti Verma Verma and Kamini Prajapati Prajapati and Anup Kumar Sirbaiya Sirbaiya and Shivani Singh Singh and Amita Singh Singh and Deepshi Srivastava Srivastava}, journal = {Journal of Pharmaceutical Research and Integrated Medical Sciences}, year = {2026}, doi = {10.64063/3049-1681.vol.3.issue6.3}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings